Pre-clinical, Phase I/II:
Biovica operates as a fee-for-service R&D partner to Oncology Pharma, offering the DiviTum®️ TKa test as a collaborative tool, including:
- Individualized guidance and planning of TKa inclusion in clinical studies
- Execution of TKa testing in certified labs
- Analyses of TKa test results
- Discussion of results
Phase II/III:
Biovica offers CDx co-development, IVD registration, and commercialization.
